QR Code

Eribulin mesylate exerts antitumor effects via CD103

Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Kazumasa Oya, Yoshiyuki Nakamura, Rei Watanabe, Ryota Tanaka, Yuki Ichimura, Noriko Kubota, Yutaka Matsumura, Hideaki Tahara, Naoko Okiyama, Manabu Fujimoto, Toshifumi Nomura, Yasuhiro Fujisawa
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Taylor & Francis Group 2023-12-01
Rangatū:OncoImmunology
Ngā marau:
antitumor effect
CD103
eribulin mesylate
immune checkpoint
resident memory T cells
Urunga tuihono:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite